JP2004505113A5 - - Google Patents

Download PDF

Info

Publication number
JP2004505113A5
JP2004505113A5 JP2002516326A JP2002516326A JP2004505113A5 JP 2004505113 A5 JP2004505113 A5 JP 2004505113A5 JP 2002516326 A JP2002516326 A JP 2002516326A JP 2002516326 A JP2002516326 A JP 2002516326A JP 2004505113 A5 JP2004505113 A5 JP 2004505113A5
Authority
JP
Japan
Prior art keywords
protein
composition according
nucleic acid
composition
acid encoding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
JP2002516326A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004505113A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2001/023648 external-priority patent/WO2002010410A1/en
Publication of JP2004505113A publication Critical patent/JP2004505113A/ja
Publication of JP2004505113A5 publication Critical patent/JP2004505113A5/ja
Abandoned legal-status Critical Current

Links

JP2002516326A 2000-07-27 2001-07-27 単純疱疹ウイルス糖蛋白質ｄを用いた組成物及びそれを用いて免疫応答を抑制する方法 Abandoned JP2004505113A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22102500P 2000-07-27 2000-07-27
PCT/US2001/023648 WO2002010410A1 (en) 2000-07-27 2001-07-27 Compositions for and methods of using herpes simplex virus glycoprotein d to suppress immune responses

Publications (2)

Publication Number Publication Date
JP2004505113A JP2004505113A (ja) 2004-02-19
JP2004505113A5 true JP2004505113A5 (enExample) 2005-04-07

Family

ID=22826021

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002516326A Abandoned JP2004505113A (ja) 2000-07-27 2001-07-27 単純疱疹ウイルス糖蛋白質ｄを用いた組成物及びそれを用いて免疫応答を抑制する方法

Country Status (8)

Country Link
US (1) US7569218B2 (enExample)
EP (1) EP1305435B1 (enExample)
JP (1) JP2004505113A (enExample)
AT (1) ATE381351T1 (enExample)
AU (2) AU8467201A (enExample)
CA (1) CA2417364A1 (enExample)
DE (1) DE60131975T2 (enExample)
WO (1) WO2002010410A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7717271B2 (en) * 2005-12-07 2010-05-18 General Electric Company Membrane structure and method of making
US20070131609A1 (en) * 2005-12-08 2007-06-14 General Electric Company Membrane structure and method of making
US8207854B2 (en) * 2009-02-09 2012-06-26 Mach 1 Development, Inc. Shipping container integrity device and system
CN106924728B (zh) * 2009-05-22 2021-02-05 健诺西生物科学公司 针对ⅱ型单纯疱疹病毒的疫苗：诱发免疫应答的组合物和方法
EP2544693B1 (en) * 2010-03-09 2017-09-13 Biomedical Research Models, Inc. A novel mucosal vaccination approach for herpes simplex virus type-2
WO2012074881A2 (en) 2010-11-24 2012-06-07 Genocea Biosciences, Inc. Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response
JP6199878B2 (ja) 2011-11-23 2017-09-20 ジェノセア バイオサイエンシーズ， インコーポレイテッド 単純ヘルペスウイルス２型に対する核酸ワクチン：免疫応答を誘発する組成物及び方法
WO2018064232A1 (en) 2016-09-28 2018-04-05 Genocea Biosciences, Inc. Methods and compositions for treating herpes
EP4284335A1 (en) 2021-02-01 2023-12-06 RegenxBio Inc. Gene therapy for neuronal ceroid lipofuscinoses

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4235871A (en) * 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
US4394448A (en) * 1978-02-24 1983-07-19 Szoka Jr Francis C Method of inserting DNA into living cells
US4241046A (en) * 1978-11-30 1980-12-23 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
US4603112A (en) * 1981-12-24 1986-07-29 Health Research, Incorporated Modified vaccinia virus
US4945050A (en) * 1984-11-13 1990-07-31 Cornell Research Foundation, Inc. Method for transporting substances into living cells and tissues and apparatus therefor
US5036006A (en) * 1984-11-13 1991-07-30 Cornell Research Foundation, Inc. Method for transporting substances into living cells and tissues and apparatus therefor
US4897355A (en) * 1985-01-07 1990-01-30 Syntex (U.S.A.) Inc. N[ω,(ω-1)-dialkyloxy]- and N-[ω,(ω-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
US5703055A (en) * 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
DE69034168T3 (de) 1989-03-21 2013-04-11 Vical, Inc. Expression von exogenen Polynukleotidsequenzen in Wirbeltieren
US5676954A (en) * 1989-11-03 1997-10-14 Vanderbilt University Method of in vivo delivery of functioning foreign genes
US5264618A (en) * 1990-04-19 1993-11-23 Vical, Inc. Cationic lipids for intracellular delivery of biologically active molecules
US5955088A (en) * 1992-02-03 1999-09-21 Cedars-Sinai Medical Center Pharmaceutical compsition of herpes simplex virus type-1 (HSV-1), glycoproteins
CA2102918C (en) 1992-03-11 2007-05-08 Joel R. Haynes Genetic vaccine for immunodeficiency viruses
US5593972A (en) * 1993-01-26 1997-01-14 The Wistar Institute Genetic immunization
WO1994027612A1 (en) * 1993-05-20 1994-12-08 Baylor College Of Medicine Genetic therapy for cardiovascular disease
US5614503A (en) * 1993-11-12 1997-03-25 Aronex Pharmaceuticals, Inc. Amphipathic nucleic acid transporter
US5739118A (en) * 1994-04-01 1998-04-14 Apollon, Inc. Compositions and methods for delivery of genetic material
WO1995033835A1 (en) * 1994-06-02 1995-12-14 Chiron Corporation Nucleic acid immunization using a virus-based infection/transfection system
US5837533A (en) * 1994-09-28 1998-11-17 American Home Products Corporation Complexes comprising a nucleic acid bound to a cationic polyamine having an endosome disruption agent
IT1270123B (it) * 1994-10-05 1997-04-28 Dompe Spa Composizioni farmaceutiche contenenti microorganismi ingegnerizzati e loro uso per terapia
US5707618A (en) * 1995-03-24 1998-01-13 Genzyme Corporation Adenovirus vectors for gene therapy
US5756283A (en) * 1995-06-05 1998-05-26 The Trustees Of The University Of Pennsylvania Method for improved production of recombinant adeno-associated viruses for gene therapy
JP2002514056A (ja) * 1996-10-23 2002-05-14 アメリカン・ホーム・プロダクツ・コーポレーション ワクチン
MXPA00008352A (es) 1998-02-27 2002-10-17 Univ Pennsylvania Vacunas, composiciones inmunoterapeuticas y metodos para usar las mismas.

Similar Documents

Publication Publication Date Title
IL161268A0 (en) Nucleic acid and corresponding protein entitled 161p2f10b and pharmaceutical and diagnostic compositions containing the same
EP1741782A8 (en) Immunogenic polypeptides encoded by MAGE minigenes and uses thereof
IL217317A0 (en) Nucleic acid and corresponding protein entitled 161p2f10b and pharmaceutical and diagnostic compositions containing the same and uses thereof
WO2002053703A3 (en) Aav2 vectors and methods
ATE395042T1 (de) Darreichungsformen welche mikropartikel und treibgas enthalten
JP2004505113A5 (enExample)
AU2002308348A1 (en) Ganglioside-associated recombinant antibodies and the use thereof in the diagnosis and treatment of tumours
MXPA02008239A (es) Gen humano de la esquizofrenia.
EP1613345A4 (en) COMPOSITIONS AND METHODS WITH THE RESPIRATORY SYNCYTIAL VIRUS SUB-GROUP B STAMM 9320
WO1999061618A3 (en) Canine and feline immunoregulatory proteins, nucleic acid molecules, and uses thereof
WO2002077012A3 (en) Human papilloma virus immunoreative peptides
DE60131975D1 (de) Anwendung des herpes simplex virus glykoproteins-d zur unterdrückung von immunantworten
GB2395903B (en) Dickkopf 5 gene, protein and antibodies: a role in the treatment and diagnosis of insulin-resistant states
TW200509964A (en) VP1 of foot-and-mouth disease virus
DE60239753D1 (de) Impfstoff gegen infektiöses lachsanämievirus
WO2002046458A3 (en) Nucleic acids of the human abca5, abca6, abca9, and abca10 genes, vectors containing such nucleic acids and uses thereof
JP2005535281A5 (enExample)
DK0524421T3 (da) Humant herpesvirus type 6 protein p 100, de tilsvarende DNA-sekvenser, deres fremstilling og anvendelse
AU2002256019A8 (en) Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
WO2002070559A3 (en) Nuclear hormone receptor ligand binding domains
IL160651A (en) Nucleic acid and corresponding protein entitled 205pib5 and pharmaceutical compositions containing the same and uses thereof
ZA200101406B (en) DNA sequence encoding the specific and antigenic outer membrane protein of salmonella typhi.
RU2001127052A (ru) Штамм вируса Эбола "Заир Ч-15" для проведения модельных экспериментов и приготовления диагностических и вакцинных препаратов
GB0409559D0 (en) Polypeptide
Healy The Dramatic Encounter of Divine and Human Freedom in the Theology of Hans Urs von Balthasar